Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01027143 · ClinicalTrials.gov registry record · Phase 2
Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids
A Phase 2 study, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 143
- Enrollment target
NCT01027143 is a Phase 2 study that has completed, run by Nemours Children's Clinic. The registered enrollment target is 143 participants.
The verdict
NCT01027143, a Phase 2 study, has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 143 participants
- Enrollment target
Study Summary
This project will assess the effectiveness of omega-3 fatty acid supplementation in controlling asthma symptoms among obese asthmatics, and will assess if a person's genes influence response to treatment (personalized medicine). This project may improve our ability to treat asthma and our understanding of the link between obesity and asthma.
Interventions
- DIETARY_SUPPLEMENT omega-3 polyunsaturated fatty acids
- DRUG Omega-3 Fatty Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2010-07 |
| Est. Completion | 2016-10-22 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01027143
The ClinicalTrials.gov registry entry for NCT01027143 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nemours Children's Clinic, which has 108 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which omega-3 polyunsaturated fatty acids is the first listed.
NCT01027143 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01027143 about?
NCT01027143 is a clinical study titled "Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids". This project will assess the effectiveness of omega-3 fatty acid supplementation in controlling asthma symptoms among obese asthmatics, and will assess if a person's genes influence response to treatment (personalized medicine). This project may improve our ability to treat asthma and our understand...
What is the current status of trial NCT01027143?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 143 participants. The study started on 2010-07. Estimated completion is 2016-10-22.
What interventions are being tested in trial NCT01027143?
The interventions under investigation include: omega-3 polyunsaturated fatty acids (DIETARY_SUPPLEMENT), Omega-3 Fatty Acid (DRUG).
Who is sponsoring clinical trial NCT01027143?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.